addition, the duration of treatment to induce retinal reattachment is currently unknown. However, patients with IH have been treated for several months.
1,2 After 3 to 4 hours of dark adaptation, both amplitudes recover to nearly normal, especially the awave. 2 However, the recovered rod function is rapidly lost after a short light exposure or a single bright white flash. 2, 3 We describe a case of Oguchi disease with unusual findings caused by a putative heterozygous mutation in the SAG gene.
Report of a Case.
A 40-year-old woman with visual acuity of 20/20 OU had fundus abnormalities and was referred to our institute. She had photophobia but did not report night blindness. There was no autosomal dominant family history. The retina had a golden-yellow appearance ( Comment. To our knowledge, this is the first case of Oguchi disease with a distinct fundus appearance and mild electrophysiological abnormalities associated with a putative heterozygous SAG mutation. However, we cannot exclude the possibility that another mutation exists in the intron of another allele, which causes the mild phenotype in this patient.
The repetitive-flash ERG protocol was crucial for the diagnosis. It has been reported that double-or tripleflash stimulations after prolonged dark adaption induce ERG alterations in typical patients with Oguchi disease. 3 However, the use of a 30-second interval allowed us to follow the degree of rod function recovery.
Arrestin and rhodopsin kinase act in sequence to deactivate rhodopsin to stop the phototransduction cascade. 4 Results of molecular biological studies have suggested that residual arrestin activity correlates with the severity of the clinical phenotype. 5 However, in our case it was more difficult to determine the relationship between the putative heterozygous mutation of the SAG gene and the mild electrophysiological abnormalities in the rod function recovery. A modifying effect of deactivating rhodopsin should be considered.
The time required for the reappearance of the rod function demonstrated in the electrophysiological study and the time required to demonstrate the Mizuo-Nakamura phenomenon were nearly identical. We suggest that the physiological basis for the Mizuo-Nakamura phenomenon may be closely related to the abnormal deactivation of rhodopsin.
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